Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The Claudin family and its role in cancer and metastasis.
Escudero-Esparza A, Jiang WG, Martin TA. Escudero-Esparza A, et al. Front Biosci (Landmark Ed). 2011 Jan 1;16:1069-83. doi: 10.2741/3736. Front Biosci (Landmark Ed). 2011. PMID: 21196219 Review.
Claudin-5 participates in the regulation of endothelial cell motility.
Escudero-Esparza A, Jiang WG, Martin TA. Escudero-Esparza A, et al. Mol Cell Biochem. 2012 Mar;362(1-2):71-85. doi: 10.1007/s11010-011-1129-2. Epub 2011 Oct 26. Mol Cell Biochem. 2012. PMID: 22038628
Transcript analyses of stromal cell derived factors (SDFs): SDF-2, SDF-4 and SDF-5 reveal a different pattern of expression and prognostic association in human breast cancer.
Kang H, Escudero-Esparza A, Douglas-Jones A, Mansel RE, Jiang WG. Kang H, et al. Among authors: escudero esparza a. Int J Oncol. 2009 Jul;35(1):205-11. doi: 10.3892/ijo_00000330. Int J Oncol. 2009. PMID: 19513569
PGF isoforms, PLGF-1 and PGF-2, in colorectal cancer and the prognostic significance.
Escudero-Esparza A, Martin TA, Davies ML, Jiang WG. Escudero-Esparza A, et al. Cancer Genomics Proteomics. 2009 Jul-Aug;6(4):239-46. Cancer Genomics Proteomics. 2009. PMID: 19657001 Free article.
The human complement inhibitor Sushi Domain-Containing Protein 4 (SUSD4) expression in tumor cells and infiltrating T cells is associated with better prognosis of breast cancer patients.
Englund E, Reitsma B, King BC, Escudero-Esparza A, Owen S, Orimo A, Okroj M, Anagnostaki L, Jiang WG, Jirström K, Blom AM. Englund E, et al. Among authors: escudero esparza a. BMC Cancer. 2015 Oct 19;15:737. doi: 10.1186/s12885-015-1734-7. BMC Cancer. 2015. PMID: 26480818 Free PMC article.
Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer.
Englund E, Bartoschek M, Reitsma B, Jacobsson L, Escudero-Esparza A, Orimo A, Leandersson K, Hagerling C, Aspberg A, Storm P, Okroj M, Mulder H, Jirström K, Pietras K, Blom AM. Englund E, et al. Among authors: escudero esparza a. Oncogene. 2016 Oct 27;35(43):5585-5596. doi: 10.1038/onc.2016.98. Epub 2016 Apr 11. Oncogene. 2016. PMID: 27065333
Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer.
Escudero-Esparza A, Bartoschek M, Gialeli C, Okroj M, Owen S, Jirström K, Orimo A, Jiang WG, Pietras K, Blom AM. Escudero-Esparza A, et al. Oncotarget. 2016 Nov 22;7(47):76920-76933. doi: 10.18632/oncotarget.12729. Oncotarget. 2016. PMID: 27764775 Free PMC article.
The novel complement inhibitor human CUB and Sushi multiple domains 1 (CSMD1) protein promotes factor I-mediated degradation of C4b and C3b and inhibits the membrane attack complex assembly.
Escudero-Esparza A, Kalchishkova N, Kurbasic E, Jiang WG, Blom AM. Escudero-Esparza A, et al. FASEB J. 2013 Dec;27(12):5083-93. doi: 10.1096/fj.13-230706. Epub 2013 Aug 20. FASEB J. 2013. PMID: 23964079